After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that ...

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.

Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in ...

Alphabet-owned Isomorphic Labs says its first AI-designed drug is nearly ready for human trials, targeting diseases like cancer and heart failure. Nucleus_AI 2783 Stories Tuesday July 08, 2025 , 2 ...

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to know ...

Google DeepMind's drug discovery company, Isomorphic Labs, is set to launch human trials of its AI-designed drugs. The company is aiming to use cutting-edge AI to design medicines faster, cheaper ...

A Google parent-owned startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end, marking a significant milestone in pharmaceutical development as ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg News reported, citing the company's CEO Demis Hassabis.

Expect AI-made prescription drugs to be ready for clinical trials in a couple of years, predicts Google DeepMind CEO 35,048 people played the daily Crossword recently. Can you solve it faster than ...

Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup said on Monday.